DA
DCF Advisers Portfolio holdings
AUM
$208M
1-Year Return
21.52%
This Quarter Return
+6.55%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$199M
AUM Growth
+$1.72M
(+0.87%)
Cap. Flow
-$11.2M
Cap. Flow
% of AUM
-5.64%
Top 10 Holdings %
Top 10 Hldgs %
47.58%
Holding
102
New
10
Increased
16
Reduced
27
Closed
14
Top Buys
| 1 |
Pfizer
PFE
|
$1.96M |
| 2 |
VanEck Gold Miners ETF
GDX
|
$1.95M |
| 3 |
KIN
Kindred Biosciences, Inc.
KIN
|
$1.48M |
| 4 |
Altimmune
ALT
|
$1.44M |
| 5 |
Ford
F
|
$1.34M |
Top Sells
| 1 |
Oracle
ORCL
|
$3.31M |
| 2 |
AbbVie
ABBV
|
$2.82M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$2.02M |
| 4 |
AT&T
T
|
$1.87M |
| 5 |
SPDR Gold Trust
GLD
|
$1.66M |
Sector Composition
| 1 | Healthcare | 40.94% |
| 2 | Technology | 16.69% |
| 3 | Communication Services | 12.11% |
| 4 | Financials | 6.46% |
| 5 | Consumer Discretionary | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Apple
AAPL
$3.53T
| $685K | 0.24% |
5,000
-1,000
| -17% | -$137K |
|
52
Microsoft
MSFT
$3.77T
| $677K | 0.24% |
2,500
| – | – |
|
53
Vir Biotechnology
VIR
$733M
| $571K | 0.2% |
12,071
+4,879
| +68% | +$231K |
|
54
Kohl's
KSS
$1.78B
| $551K | 0.2% |
10,000
| – | – |
|
55
Ovid Therapeutics
OVID
$93.9M
| $546K | 0.19% |
139,701
+30,700
| +28% | +$120K |
|
56
Nektar Therapeutics
NKTR
$625M
| $537K | 0.19% |
2,087
| – | – |
|
57
KraneShares CSI China Internet ETF
KWEB
$8.43B
| $523K | 0.19% |
7,500
-10,000
| -57% | -$697K |
|
58
Box
BOX
$4.67B
| $511K | 0.18% |
20,000
-20,000
| -50% | -$511K |
|
59
Equillium
EQ
$64.7M
| $457K | 0.16% |
+77,538
| New | +$457K |
|
|
PARA
60
DELISTED
Paramount Global Class B
PARA
| $452K | 0.16% |
+10,000
| New | +$452K |
|
|
AYX
61
DELISTED
Alteryx, Inc.
AYX
| $430K | 0.15% |
5,000
-1,625
| -25% | -$140K |
|
62
Gen Digital
GEN
$18.2B
| $408K | 0.14% |
15,000
-15,000
| -50% | -$408K |
|
63
Genmab
GMAB
$16.7B
| $408K | 0.14% |
10,000
| – | – |
|
64
Freeport-McMoran
FCX
$65.5B
| $371K | 0.13% |
10,000
| – | – |
|
|
QTNT
65
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $368K | 0.13% |
2,525
-763
| -23% | -$111K |
|
66
Aptiv
APTV
$17.4B
| $354K | 0.13% |
2,250
-5,250
| -70% | -$826K |
|
67
Biogen
BIIB
$20.2B
| $346K | 0.12% |
+1,000
| New | +$346K |
|
|
ARNA
68
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $341K | 0.12% |
5,000
| – | – |
|
|
APTX
69
DELISTED
Aptinyx Inc. Common Stock
APTX
| $323K | 0.11% |
114,000
-16,000
| -12% | -$45.3K |
|
70
TSMC
TSM
$1.21T
| $300K | 0.11% |
+2,500
| New | +$300K |
|
71
Matinas BioPharma
MTNB
$9.61M
| $299K | 0.11% |
7,719
-281
| -4% | -$10.9K |
|
|
TBHC
72
The Brand House Collective, Inc. Common Stock
TBHC
$33M
| $252K | 0.09% |
11,000
+500
| +5% | +$11.5K |
|
73
Air T
AIRT
| $214K | 0.08% |
+8,673
| New | +$214K |
|
74
Lineage Cell Therapeutics
LCTX
$276M
| $212K | 0.08% |
74,500
+53,500
| +255% | +$152K |
|
75
Sangamo Therapeutics
SGMO
$159M
| $157K | 0.06% |
13,100
-900
| -6% | -$10.8K |
|